Scil Proteins operates its business in the strongly growing area of pharmaceutical manufacturing, i.e. antibody manufacturing and non-antibody/vaccine manufacturing as well as diagnostics. The company generates superior ligands for robust and cost effective products. A multi-disciplinary team of experts that follow the project from concept to supply of ready-to-use devices guarantees the best possible outcome in the shortest time. Our partners are based in the biotech, pharmaceutical and life science industries and academia.
We offer the discovery and supply of affinity ligands and grant commercial licenses to our partners. Scil Proteins seeks strategic partners and specialists with a strong existing stake in the core markets biopharmaceutical manufacturing and targeted carriers for further development and commercialization of the affinity ligands.